Nuzenio

Maintains Neutral Rating

Maintains Neutral Rating news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 4 publisher sources 100/100 entity strength

Latest news

ETSY Maintains Neutral Rating by Citigroup -- Price Target Raised to $92 - GuruFocusGuruFocus · Sat, 08 Aug 2026 01:05:28 GMTFISV Maintains Neutral Rating by JP Morgan -- Price Target Lowered to $60 - GuruFocusGuruFocus · Fri, 07 Aug 2026 23:21:54 GMTWedbush Adjusts Price Target on Zentalis Pharmaceuticals to $5 From $4, Maintains Neutral Rating - MoomooMoomoo · Fri, 07 Aug 2026 20:53:39 GMTUBS Adjusts Orion S.A Price Target to $8 From $7.50, Maintains Neutral Rating - MoomooMoomoo · Fri, 07 Aug 2026 20:11:26 GMTWhy ResMed Is Dropping 6.1%: Piper Sandler Maintains Neutral - AlphaStreetAlphaStreet · Fri, 07 Aug 2026 19:26:31 GMTTGT Maintains Neutral Rating -- Price Target Raised to $157 - GuruFocusGuruFocus · Fri, 07 Aug 2026 19:19:39 GMTUBS Adjusts RealReal Price Target to $16 From $14, Maintains Neutral Rating - MoomooMoomoo · Fri, 07 Aug 2026 18:37:20 GMTFROG Maintains Neutral by Piper Sandler -- Price Target Raised t - GuruFocusGuruFocus · Fri, 07 Aug 2026 18:30:32 GMT

Timeline

Sat, 08 Aug 2026 01:05:28 GMTETSY Maintains Neutral Rating by Citigroup -- Price Target Raised to $92 - GuruFocus
Fri, 07 Aug 2026 23:21:54 GMTFISV Maintains Neutral Rating by JP Morgan -- Price Target Lowered to $60 - GuruFocus
Fri, 07 Aug 2026 20:53:39 GMTWedbush Adjusts Price Target on Zentalis Pharmaceuticals to $5 From $4, Maintains Neutral Rating - Moomoo
Fri, 07 Aug 2026 20:11:26 GMTUBS Adjusts Orion S.A Price Target to $8 From $7.50, Maintains Neutral Rating - Moomoo
Fri, 07 Aug 2026 19:26:31 GMTWhy ResMed Is Dropping 6.1%: Piper Sandler Maintains Neutral - AlphaStreet
Fri, 07 Aug 2026 19:19:39 GMTTGT Maintains Neutral Rating -- Price Target Raised to $157 - GuruFocus

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Maintains Neutral Rating.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.